Topics:

ubmslateCL-logo-ubm

CL Mobile Menu

Diabetes Type 2

SGLT2 Inhibitor Q & A

Four questions for you to answer, four facts you need to know.

 

Diabetes Type 2

©molekuul.be/Shutterstock.com

Take a short break from the clinic and try 2 quick questions about the injectable gut hormone analogs.

© Peter Bernik/Shutterstock.com

Questions you were afraid to ask about weight-loss modalities in the context of obesity and type 2 diabetes are answered here.

© sacura/Shutterstock.com

In the diabetes news: diet and physical activity programs may help prevent type 2 DM, patiromer shows promise for hyperkalemia, metformin may treat portal hypertension.

© 117135526/Shutterstock.com

A protective endothelial function effect may be seen with exenatide in patients who have long-standing type 2 diabetes in the postprandial period after short-term therapy.

GLP-1 agonists quiz

Incretin mimetic therapy for type 2 diabetes has been on the market for more than 10 years. Find out what you've learned about the GLP-1 agonists, here.

© SSSCCC/Shutterstock.com

Heading the diabetes news: therapeutic targeting of cellular senescence, food order affects glucose and insulin levels, sugar causes heart muscle damage, central obesity genetic score linked to type 2 DM risk.

What do current guidelines recommend as first-line treatment for patients like 51-year-old TK? Check out these options.

Pages

Subscribe to Diabetes Type 2 on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.